Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
adequacy, Allen, AMP, Amy, apportionment, Arnsten, avendor, biosimilar, blind, Chao, Choline, chosen, complementary, Concerta, contemplated, contractor, core, correspondingly, corrupt, cure, customary, Demeclocycline, device, earliest, Education, enlarged, entacapone, entirety, extreme, fast, Fenoglide, forfeiture, gap, genericized, grace, GSK, Guanfacine, harder, headquarter, Hunt, illegal, imposition, improper, impropriety, inaccuracy, inadvertently, interlocutory, Intuniv, jeopardize, Jhunan, Lannett, licensee, LifeCycle, Lyrica, magistrate, meaningful, Medco, Methylphenidate, mitigate, modification, motor, MSP, outpatient, Overview, parallel, Pasko, pathway, peer, pledge, pledged, powder, pregablin, prepaid, prepay, Pristiq, privacy, proscribed, prostate, PurduePharma, Rakic, randomized, recovery, Respiratory, restraining, Shionogi, Simcor, Singapore, straight, symptom, therapy, timeline, Trilipix, undergone, undrawn, unexpected, unrestricted, Vytorin, worn, xiii, xiv, xv, xvi, xvii
Removed:
acquired, affecting, amyotrophic, appealed, assumed, Barr, book, clear, compound, consecutive, dismissal, dismissing, eleven, eliminate, equally, expanded, expenditure, fewer, flexibility, GATT, HCl, hearing, history, Industrie, innovator, Minocycline, modify, occurrence, pace, permanent, pertinent, planning, prime, ratified, reached, Rilutek, riluzole, Round, Sante, seasonal, send, slower, strategically, unavailability, Uruguay, vigorously, virtue, Winthrop
Filing tables
Filing exhibits
Related press release
IPXL similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We have issued our reports dated February 25, 2011, with respect to the consolidated financial statements, schedule, and internal control over financial reporting included in the Annual Report of Impax Laboratories, Inc. and Subsidiaries on Form 10-K for the year ended December 31, 2010. We hereby consent to the incorporation by reference of said reports in the Registration Statements of Impax Laboratories, Inc. and Subsidiaries on Form S-8 (File No. 333-158259 effective March 27, 2009 and File No. 333-168584 effective August 6, 2010).
/s/ GRANT THORNTON LLP
Philadelphia, Pennsylvania
February 25, 2011
February 25, 2011